409 related articles for article (PubMed ID: 21180614)
1. Managing bile acid diarrhoea.
Walters JR; Pattni SS
Therap Adv Gastroenterol; 2010 Nov; 3(6):349-57. PubMed ID: 21180614
[TBL] [Abstract][Full Text] [Related]
2. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
[TBL] [Abstract][Full Text] [Related]
3. Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy.
Orekoya O; McLaughlin J; Leitao E; Johns W; Lal S; Paine P
Clin Med (Lond); 2015 Jun; 15(3):252-7. PubMed ID: 26031975
[TBL] [Abstract][Full Text] [Related]
4.
Mena Bares LM; Carmona Asenjo E; García Sánchez MV; Moreno Ortega E; Maza Muret FR; Guiote Moreno MV; Santos Bueno AM; Iglesias Flores E; Benítez Cantero JM; Vallejo Casas JA
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):37-47. PubMed ID: 27765536
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.
Wedlake L; A'Hern R; Russell D; Thomas K; Walters JR; Andreyev HJ
Aliment Pharmacol Ther; 2009 Oct; 30(7):707-17. PubMed ID: 19570102
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study.
Flores V; Martínez-Lozano H; Bighelli F; Orcajo J; García-Lledó J; Alonso-Farto JC; Menchén L
BMC Gastroenterol; 2021 Feb; 21(1):56. PubMed ID: 33563227
[TBL] [Abstract][Full Text] [Related]
8. Methods for diagnosis of bile acid malabsorption in clinical practice.
Vijayvargiya P; Camilleri M; Shin A; Saenger A
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1232-9. PubMed ID: 23644387
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
Borup C; Vinter-Jensen L; Jørgensen SPG; Wildt S; Graff J; Gregersen T; Zaremba A; Borup Andersen T; Nøjgaard C; Timm HB; Rainteau D; Hansen SH; Rumessen JJ; Munck LK
Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):321-331. PubMed ID: 36758570
[TBL] [Abstract][Full Text] [Related]
10. Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.
Appleby RN; Bajor A; Gillberg PG; Graffner H; Simrén M; Ung KA; Walters J
United European Gastroenterol J; 2017 Apr; 5(3):380-388. PubMed ID: 28507750
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.
Valentin N; Camilleri M; Altayar O; Vijayvargiya P; Acosta A; Nelson AD; Murad MH
Gut; 2016 Dec; 65(12):1951-1959. PubMed ID: 26347530
[TBL] [Abstract][Full Text] [Related]
12. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Walters JR; Tasleem AM; Omer OS; Brydon WG; Dew T; le Roux CW
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1189-94. PubMed ID: 19426836
[TBL] [Abstract][Full Text] [Related]
13. Incidence and predictive factors for positive
Murray IA; Murray LK; Woolson KL; Sherfi H; Dixon I; Palmer J; Sulkin T
Scand J Gastroenterol; 2017; 52(6-7):698-703. PubMed ID: 28276822
[TBL] [Abstract][Full Text] [Related]
14. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.
Kurien M; Evans KE; Leeds JS; Hopper AD; Harris A; Sanders DS
Scand J Gastroenterol; 2011 Jul; 46(7-8):818-22. PubMed ID: 21492055
[TBL] [Abstract][Full Text] [Related]
15. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption.
Wilcox C; Turner J; Green J
Aliment Pharmacol Ther; 2014 May; 39(9):923-39. PubMed ID: 24602022
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the understanding of bile acid malabsorption.
Pattni S; Walters JR
Br Med Bull; 2009; 92():79-93. PubMed ID: 19900947
[TBL] [Abstract][Full Text] [Related]
17. [Results of the 75selenium homotaurocholic acid retention test (SeHCAT test) in diagnosis of diarrhea].
Balzer K; Schmitt G; Reiners C; Goebell H
Med Klin (Munich); 1995 Jan; 90(1):27-32. PubMed ID: 7885300
[TBL] [Abstract][Full Text] [Related]
18. Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.
Barkun AN; Love J; Gould M; Pluta H; Steinhart H
Can J Gastroenterol; 2013 Nov; 27(11):653-9. PubMed ID: 24199211
[TBL] [Abstract][Full Text] [Related]
19. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea.
Borghede MK; Schlütter JM; Agnholt JS; Christensen LA; Gormsen LC; Dahlerup JF
Eur J Intern Med; 2011 Dec; 22(6):e137-40. PubMed ID: 22075299
[TBL] [Abstract][Full Text] [Related]
20. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT.
Nyhlin H; Merrick MV; Eastwood MA
Gut; 1994 Jan; 35(1):90-3. PubMed ID: 8307458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
